Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jennifer Gansert, MD, PhD
Jonsson Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peter Maccallum Cancer Centre
East Melbourne, Victoria, Australia
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Centre Hospitalier Lens
Lens, France
- Saint Bartholomew'S Hospital
London, England, United Kingdom
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Rocky Mountain Cancer Centers - Denver Midtown
Denver, Colorado, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University
New York, New York, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2004
- Primary completion
- —
- Completion
- —
- Last update posted
- 8 Jan 2013
- Registered enrollment
- 0
- Registry id
- NCT00081068
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.